Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Schoenberg Mark
Over the trailing 90 days, Schoenberg Mark (Other Officer at UroGen Pharma Ltd.) sold $1.2M of stock in URGN, per 6 SEC Form 4 transactions.
- Role
- Other Officer
- Companies
- URGN
- Window
- Trailing 90 days · 6 transactions · CIK 1763581
- Net activity
- −$1.2M ($0 bought · $1.2M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | 6 | — | $1.2M | −$1.2M |
Transactions (6)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-09 | URGN | Sell | 10.0K | $400K | Open market or private sale |
| 2026-06-22 | URGN | Sell | 10.0K | $350K | Open market or private sale |
| 2026-06-08 | URGN | Sell | 10.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-08 | URGN | Buy | 10.0K | $0 | Exercise or conversion of derivative security |
| 2026-06-08 | URGN | Sell | 5.2K | $143K | Open market or private sale |
| 2026-05-08 | URGN | Sell | 10.0K | $300K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Schoenberg's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.